CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net loss	$ (68,786)	$ (79,887)	$ (8,565)
Adjustments to reconcile net loss to net cash provided by operating activities:
(Gain) loss on sale of discontinued operations, net of taxes	(14,933)	6,260	0
Income from discontinued operations, net of taxes	(1,808)	(6,901)	(129)
Depreciation	50,534	50,777	52,649
Amortization of intangible assets	9,962	9,881	9,899
Impairment of goodwill related to discontinued operations	0	0	13,500
Non-cash interest expense, net	10,289	8,263	5,277
Deferred income taxes	(28,672)	(1,948)	6,861
Non-cash taxes	40,562	56,500	0
Gain on bargain purchase	(17,262)	0	(11,720)
(Gain) loss on sale of assets	(120)	(2,782)	376
Non-cash restructuring and other charges, net	2,622	11,226	3,853
Impairment of intangible assets	33,367	0	0
Loss (gain) on early extinguishment of debt, net	11,324	12,487	(4,011)
Provisions for bad debts	4,392	2,024	2,284
Provisions for inventory obsolescence	6,523	3,588	3,416
Stock-based compensation provision	3,739	5,333	8,716
Gain on insurance claim	(2,670)	0	0
Changes in operating assets and liabilities, excluding the effects of acquired businesses:
Accounts receivable	(31,686)	26,594	(8,403)
Inventories	(40,622)	(617)	20,453
Accounts payable and accrued compensation and related liabilities	69,848	(13,291)	13,650
Other working capital changes	4,047	(29,050)	(14,948)
Other, net	(18,335)	(15,613)	(23,529)
Net cash provided by operating activities of continuing operations	22,315	42,844	69,629
Net cash provided by operating activities of discontinued operations	5,878	9,221	10,693
Net cash provided by operating activities	28,193	52,065	80,322
Cash flows from investing activities:
Cost of business acquisitions, net of cash acquired	(33,166)	(644)	(59,719)
Capital expenditures	(29,235)	(20,563)	(15,572)
Purchase of investment	(1,650)	(350)	0
Proceeds from insurance claim	3,036	0	0
Proceeds from sale of property, plant and equipment	8,304	7,978	11,114
Proceeds from sale of intangible asset	0	5,700	0
Net cash used in investing activities of continuing operations	(52,711)	(7,879)	(64,177)
Net cash provided by (used in) investing activities of discontinued operations	45,214	39,533	(635)
Net cash (used in) provided by investing activities	(7,497)	31,654	(64,812)
Cash flows from financing activities:
Repayment of 10.5% senior notes	0	(169,875)	0
Repayment of 7.875% senior subordinated notes	(67,848)	(214,831)	(8,952)
(Repayment) borrowing of Term Loan B due 2016	(388,205)	31,844	(23,800)
Repayment of 8.375% senior subordinated notes	0	(24,787)	(5,363)
Payment of financing related costs and expenses and debt issuance discounts	(15,570)	(37,836)	(2,675)
Repayments of other long-term debt	(7,365)	(4,846)	(6,403)
Purchase and retirement of common stock upon vesting of RSUs	(660)	(735)	(1,283)
Proceeds from issuance of 11.5% senior notes	0	225,000	0
Proceeds from issuance of 7% senior exchangeable notes	0	86,250	0
(Repayment) borrowings under Revolving Credit Facility, net	(18,000)	18,000	0
Proceeds from issuance of 15% Unsecured Term Loan due 2017	50,000	0	0
Repayment of 15% Unsecured Term Loan due 2017	(40,000)	0	0
Proceeds from exercise of stock options	98	0	356
Repayment of Term Loan Facility due 2017	(30,900)	0	0
Proceeds from issuance of Term Loan Facility due 2017	360,000	0	0
Borrowings under ABL Facility due 2017	699,200	0	0
Repayments under ABL Facility due 2017	(577,800)	0	0
Proceeds from equipment loan	20,000	0	0
Repayments of equipment loan	(500)	0	0
Net cash used in financing activities of continuing operations	(17,550)	(91,816)	(48,120)
Net cash used in financing activities of discontinued operations	0	(1,652)	0
Net cash used in financing activities	(17,550)	(93,468)	(48,120)
Effect of exchange rate changes on cash and cash equivalents	73	106	614
Net increase (decrease) in cash and cash equivalents	3,219	(9,643)	(31,996)
Cash and cash equivalents at beginning of period	8,110	17,753	49,749
Cash and cash equivalents at end of period	$ 11,329	$ 8,110	$ 17,753